NASDAQ:CYTX - Cytori Therapeutics, Inc.
$0.23
 $-0.00
-1.26%
12:40PM EDT
2019-07-22
Cytori Therapeutics, Inc. (Cytori) is a biotechnology company engaged in the development of treatments and devices for a range of disorders using cells as a key part of the therapy. The Company develops cellular therapeutics formulated and optimized for specific diseases and medical conditions and related products. It is focused on developing primary product, Cytori Cell Therapy, for patients with scleroderma hand dysfunction, orthopedic disorders, cardiovascular disease, urinary incontinence and thermal burns, including those complicated by radiation. Its cellular therapeutics are collectively known by the name, Cytori Cell Therapy, which consists of a heterogeneous population of specialized cells, including stem cells that are involved in response to injury, repair and healing. These cells are extracted from an adult patient's own adipose tissue using its automated, enzymatic, sterile Celution System devices and consumable sets at the place where the patient is receiving their care. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CYTX     avg for
industry  
  avg for
sector  
42 stocks weight:  3. 69   217. 37   399. 45  
42 stocks rank:  4. 35 K 1. 27 K 716. 99  
# analyst opinions:  1. 00   13. 21   13. 71  
mean recommendation:  2. 00   2. 10   2. 04  

quick ratio:  0. 24   5. 49   1. 88  
current ratio:  0. 46   5. 87   2. 36  

target price low:  0. 23   83. 44   114. 90  
target price avg:  0. 23   106. 20   137. 90  
target price high:  0. 23   132. 30   158. 97  
1-yr high:  0. 93   111. 86   142. 57  
last close:  0. 24   86. 79   125. 44  
50-day avg:  0. 25   86. 68   122. 63  
200-day avg:  0. 30   89. 22   121. 38  
1-yr low:  0. 22   69. 78   100. 51  
volume:  182. 82 K 2. 62 M 3. 43 M
50-day avg volume:  639. 86 K 3. 20 M 4. 16 M
200-day avg volume:  549. 75 K 2. 99 M 4. 75 M

1-day return:  -1. 08 % -1. 30 % -0. 99 %
this week return:  2. 19 % 0. 45 % -0. 20 %
12-wk return:  -23. 39 % 0. 94 % 4. 84 %
52-wk return:  -76. 17 % -1. 30 % 10. 55 %

enterprise value (EV):  17. 84 M 45. 10 B 122. 38 B
market cap:  5. 26 M 38. 96 B 108. 40 B
EBITDA:  -10. 00 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -1. 78   5. 38   11. 93  
enterprise/revenue (EV/R):  2. 77   57. 92   10. 21  
total revenue:  6. 45 M 9. 91 B 39. 98 B
total debt:  16. 59 M 10. 90 B 17. 48 B
debt/equity:  430. 10   57. 18   120. 05  
net income (common):  -13. 86 M 2. 07 B 4. 05 B

shares outstanding:  22. 16 M 538. 09 M 1. 24 B
shares:  22. 12 M 548. 00 M 1. 22 B
shares short:  152. 21 K 10. 98 M 11. 87 M
shares short prior month:  83. 21 K 9. 32 M 12. 05 M
short ratio:  0. 36   5. 60   3. 34  
short % of float:  0. 70 % 6. 48 % 2. 64 %
total cash/share:  0. 17   10. 98   9. 19  
total cash:  3. 87 M 5. 93 B 6. 10 B
free cash flow:  -6. 17 M 2. 92 B 4. 55 B
operating cash flow:  -11. 13 M 3. 80 B 5. 78 B

book value:  0. 18   13. 35   27. 45  
price/book:  1. 35   4. 60   8. 78  
gross profits:  -3. 12 M 7. 44 B 36. 13 B
operating margins:  -185. 34 % -308. 40 % -28. 55 %
EBITDA margins:  -155. 09 % 13. 17 % 23. 38 %
profit margins:  -176. 47 % 10. 44 % 14. 18 %
gross margins:  -42. 68 % 35. 80 % 55. 40 %

1-yr max volatility:  43. 16 % --- ---
1-yr mean volatility:  4. 61 % 1. 66 % 1. 03 %

1-yr EPS:  -1. 20   2. 10   4. 23  
forward EPS:  -0. 60   3. 45   7. 10  
P/E:  -0. 20   1. 90   32. 10  
forward P/E:  -0. 40   6. 46   15. 47  
PE/G:  0. 02   0. 70   -0. 54  
growth:  -12. 60 % 265. 63 % 79. 11 %
earnings high:  -0. 27   0. 89   1. 68  
earnings avg:  -0. 30   0. 70   1. 57  
earnings low:  -0. 32   0. 46   1. 46  
revenue high:  2. 00 M 2. 57 B 11. 07 B
revenue avg:  1. 89 M 2. 51 B 10. 91 B
revenue low:  1. 79 M 2. 45 B 10. 73 B
return on assets:  -29. 13 % -2. 34 % 5. 28 %
return on equity:  -184. 40 % -90. 08 % 133. 53 %
revenue growth:  -12. 60 % 265. 25 % 73. 68 %
revenue/share:  0. 56   12. 72   60. 04  

beta (1yr vs S&P500):  1. 05   1. 27   0. 91  
sharpe (1yr):  -0. 71   0. 16   0. 77  

held % insiders:  1. 96 % 6. 06 % 3. 29 %
held % institutions:  5. 46 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : CYTX
.    100.633 =       100.633 :: --> INITIAL WEIGHT <--
.    - 1.195 =        99.438 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 1.943 =       193.172 :: P/E factor
.    x 2.209 =       426.708 :: PE/G factor
.    x 1.662 =       709.023 :: beta factor
.    x 0.895 =        634.51 :: sharpe factor
.    x 2.079 =      1319.084 :: current ratio factor
.    x 1.465 =      1931.825 :: quick ratio factor
.    x 1.881 =      3633.795 :: short ratio factor
.    x 1.048 =      3807.441 :: EV/R factor
.    x 1.007 =      3833.045 :: price-to-book factor
.    x 0.778 =      2981.414 :: debt-to-revenue factor
.    x 2.301 =      6861.358 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      14551.52 :: sector+industry 1-year gains factor
.    x 1.009 =     14688.713 :: industry 12-weeks return factor
.    x 1.308 =       19211.2 :: industry 2-weeks return factor
.    x 0.961 =     18465.714 :: "drift" penalty 1 days ago
.     x 0.94 =      17353.57 :: "drift" penalty 2 days ago
.    / 2.199 =       7893.31 :: overall "drift" factor
.    x 0.636 =      5023.751 :: largest single-day jump factor
.    x 0.059 =       296.518 :: low price factor
.    x 0.183 =        54.116 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.     x 0.36 =        19.482 :: forward EPS factor
.    x 0.767 =        14.951 :: forward P/E factor
.    x 1.185 =        17.713 :: industry recommendation factor
.    x 2.068 =        36.638 :: company recommendation factor
.    x 1.003 =        36.739 :: factor historical industry gain for week 29
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         2.462 :: reduced for readability
.    + 1.228 =          3.69 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                       3.69 :: FINAL WEIGHT for NASDAQ:CYTX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org